The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 28, 2016

Filed:

Aug. 14, 2013
Applicant:

Verastem, Inc., Needham, MA (US);

Inventors:

Andrew Xian Chen, San Diego, CA (US);

Yali J. Tsai, La Jolla, CA (US);

Assignee:

VERASTEM, INC., Needham, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/44 (2006.01); A61K 31/435 (2006.01); A61K 9/107 (2006.01); A61K 31/5377 (2006.01); C07D 213/74 (2006.01);
U.S. Cl.
CPC ...
A61K 9/107 (2013.01); A61K 31/5377 (2013.01); C07D 213/74 (2013.01); A61K 31/435 (2013.01);
Abstract

The invention is directed to formulations of bioactive compounds of limited water solubility, inhibitors of focal adhesion kinase (FAK) of the 2,4-diaminopyridine class, adapted for oral administration to patients. The formulations are self-emulsifying in the gastrointestinal tract of the patients, providing enhanced absorption and bioavailability of the bioactive compounds as dispersions or emulsions in an oil base. For example, esters of PEG-ylated glycerol can be used as the oil, in conjunction with surfactants such as lecithin and TEPG succinate and solubilizers such as PEG 400 to provide useful oral formulations for administration to patients having a malcondition wherein inhibition of FAK is medically indicated, such as cancer or arthritis.


Find Patent Forward Citations

Loading…